News: QuantumBio Selected for NIH SBIR Commercialization Assistance Program

On October 5, 2010 QuantumBio was chosen to participate in the Commercialization Assistance Program (CAP) sponsored by the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Program.

From the NIH-CAP site: “NIH-CAP is a specialized technical assistance program for SBIR Phase II awardees. CAP is designed to help promising small life science companies develop their commercial businesses and transition their SBIR – developed technologies into the marketplace.Assisting small businesses is a top priority for the NIH in ensuring the success of the SBIR programs and maximizing the agency’s investment. Since the program’s inception in 2003, NIH has worked with Larta Institute of Los Angeles, California to provide approximately 550 participants with individualized assistance toward accomplishing their commercialization goals. This is achieved through training workshops, individual mentoring and consulting sessions, as well as public events in which companies present their technologies to the investment community, potential strategic partners and licensees.”

On November 2, 2010 QuantumBio will participate in the first of several meetings with NIH staff and business mentors in order to explore hone the commercialization efforts of the Company. We expect that through this program, we will build numerous relationships that will aide our grown in the months and years to come.